This is consistent with previous observations that suggest while HLA-A/B are associated with neo-epitope presentation to, and activation of, CD8+ T cells, HLA-C is more strongly associated with interactions with killer Ig-like receptors expressed by NK cells (39), implicating these 2 immune effector cells in cancer immunosurveillance to varying degrees. The gene discussed is CD8A; the disease is cancer.